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Human cystatin C (hCC) is a small but very intriguing protein. Produced by all nucleated
cells is found in almost all tissues and body fluids where, at physiological conditions,
plays a role of a very potent inhibitor of cysteine proteases. Biologically active hCC is
a monomeric protein but during cellular trafficking it forms dimers, transiently losing its
inhibitory activity. In vitro, dimerization of cystatin C was observed for the mature protein
during crystallization trials, revealing that the mechanism of this process is based on the
three dimensional swapping of the protein domains. In our work we have focused on
the impact of two proposed “hot spots” in cystatin C structure on its conformational
stability. Encouraged by promising results of the theoretical calculations, we designed
and produced several hCC hinge region point mutation variants that display a variety
of conformational stability and propensity for dimerization and aggregation. A similar
approach, i.e., rational mutagenesis, has been also applied to study the amyloidogenic
L68Q variant to determine the contribution of hydrophobic interactions and steric effect
on the stability of monomeric cystatin C. In this overview we would like to summarize the
results of our studies. The impact of a particular mutation on the properties of the studied
proteins will be presented in the context of their thermal and mechanical stability, in vitro
dimerization tendency as well as the outcome of crystallization. Better understanding of
the mechanism and, especially, factors affecting conformational stability of cystatin C and
access to stable monomeric and dimeric versions of the protein opens new perspectives
in explaining the role of dimers and the domain swapping process in hCC oligomerization,
as well as designing potential inhibitors of this process.
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INTRODUCTION
More than 50 years after its discovery in human body fluids
(Clausen, 1961) and 30 years after determination of its amino
acid sequence (Grubb and Löfberg, 1982), cystatin C (hCC) still
attracts the attention of many groups of scientists. Basic, unbiased
search of the PubMed database yields over 2800 hits for “cystatin
C” as a subject, most of them focused on clinical application of
this protein as a valuable biomarker of various disease states. The
original application of cystatin C as a measure of the glomerular
filtration rate (Grubb et al., 1985) and a marker of kidneys func-
tion (Grubb, 1992; Page et al., 2000; Curhan, 2005) has expanded
and now hCC is investigated also as a prognostic marker of car-
diovascular events (Zethelius et al., 2008; Taglieri et al., 2009; Shin
et al., 2012), as well as several forms of cancer (Turk et al., 2008).
Another branch of the research is focused on the role of cystatin
C in Alzheimer’s disease, as both a biomarker and potential tar-
get for therapy (Levy, 2008; Zerovnik, 2009; Craig-Schapiro et al.,
2011).
Less attention seems to be paid to cystatin C on a molecular
level. Comparing to its homologues from the stefin family, stefins
A and B, which are extensively studied by Turk, Zerovnik and co-
workers (Zerovnik et al., 1998; Zerovnik and Kopitar-Jerala, 2006;
Ceru et al., 2008; Zerovnik et al., 2010), the literature concerning
cystatin C is much more scarce. Until last year the structure of the
monomeric hCC was not determined (Kolodziejczyk et al., 2010;
Orlikowska et al., 2011b), even though the biological activity of
this protein is strictly dependent on its oligomeric state—only
monomeric cystatin C is an active inhibitor of the papain-like
cysteine proteases (Ekiel and Abrahamson, 1996). The best stud-
ied feature of cystatin C is its dimerization. Systematic studies
of this process were initiated by Ekiel and Abrahamson (1996)
and its mechanism was solved 5 years later, when it was shown
to be based on the three dimensional domain swapping phe-
nomenon (Janowski et al., 2001). Further studies, executed by
Grubb and co-workers connected hCC ability to swap domains
with its fibrillization propensities (Nilsson et al., 2004; Wahlbom
et al., 2007). Interestingly, in the family of cysteine proteases
inhibitors [I25, MEROPOS classification (Rawlings et al., 2012)],
the propensity to exchange folding subunits is not limited only to
cystatin C. Also members of the cystatin subfamily I25A—stefin
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A and B, as well as an avian cystatin C analogue (chicken cys-
tatin, cC) also are able to undergo the same process. Intertwined
dimers of stefin A and cC were shown to form upon nearly
complete unfolding, resulting either from elevated temperature,
or presence of relatively high concentration of denaturing agent
(guanidinium chloride) and the structure of dimeric stefin A
was confirmed by NMR studies (Jerala and Zerovnik, 1999;
Staniforth et al., 2001). Domain-swapped dimer of Y31-stefin
B P79S mutant was observed both in solution and in the crys-
tal form as a part of a tetramer (Jenko Kokalj et al., 2007), in
which two dimers interact with each other via the “hand shak-
ing” mechanism, involving the exchange of two hairpin loop
structures.
Special case of cystatin C dimerization refers to its natu-
rally occurring point mutation variant, in which native leucine
in position 68 is substituted by glutamine (Palsdottir et al.,
1989). Caused by this mutation disruption of a network of the
hydrophobic interactions, holding together the core of the pro-
tein, results in a strong destabilization of the molecule (Janowski
et al., 2001). In vitro this feature of cystatin C variant is reflected
by significantly increased tendency of L68Q hCC for dimerization
and aggregation (Abrahamson and Grubb, 1994); in vivo—leads
to massive formation of amyloid-like deposits of the protein in
brain arteries and development of a lethal disease: hereditary cys-
tatin C amyloid angiopathy (HCCAA; Palsdottir et al., 2006).
The wild-type cystatin C is relatively stable in a monomeric
form, however, it was shown that in vivo it undergoes transient
dimerization during its post-translational trafficking and secre-
tion (Merz et al., 1997). Whether the mechanism of this process
is based on domain swapping was not investigated.
The relationships between cystatin C dimerization and
oligomerization, localization, and activity are even more intrigu-
ing if one considers that most of the cysteine proteases are
localized inside the cell, whereas hCC is an extracellular pro-
tein. Therefore, there must exist the mechanism that brings these
molecules together, the more, that substantial and rapid hCC
uptake was observed for some cancer cell lines (Ekström et al.,
2008) and in neuroblastoma cells (Wallin et al., 2010). It is tempt-
ing to hypothesize that at some stages of cystatin C trafficking to
and from the cell it adopts the inactive, dimeric, domain swapped
form which, later on, undergoes monomerization and activation
in the response to increased levels of its target proteases.
Regardless the substantial efforts and many experimental and
theoretical studies aimed at developing a comprehensive model
for the domain swapping, this process still remains quite elusive
and very case-sensitive. Large structural and sequence diversity
of proteins undergoing the domain swapping process does not
simplify the efforts (Shameer et al., 2011). However, there are
some conclusions that were reached, focusing the attention of the
researchers on two main molecular factors that may be involved
in increased protein’s propensity to swap domains. First of them
are local strains arising from the presence of unfavorable amino
acid sequence (Sirota et al., 2008), whereas the second one points
to the crucial role of flexible hinge regions in the protein struc-
ture (Dehouck et al., 2003; Yang et al., 2004; Ding et al., 2006;
Gronenborn, 2009). Human cystatin C (hCC) is a unique pro-
tein that allows studies of the impact of both these factors on the
domain swapping, dimerization, and oligomerization.
INTRAMOLECULAR DETERMINANTS OF CYSTATIN C
DOMAIN SWAPPING PROCESS
Cystatin C is a small, basic protein, which 120 amino acids long
polypeptide chain is folded to create a compact, fist-like molecule,
with a helical “thumb” wrapped by four “fingers” created by anti-
parallel β-strands (Kolodziejczyk et al., 2010; Figure 1A). Two
β-hairpin loops, L1 and L2, localized on the one pole of the
molecule form, together with the N-terminal part, the inhibitory
active site recognized by the main target of all cystatins—cysteine
proteases. The opposite, mainly unstructured, appending struc-
ture (AS) contains the region recognized by the other group of
enzymes—legumains (Alvarez-Fernandez et al., 1999). The loop
L1 is also vitally engaged in cystatin C dimerization. It joins two
hCC fragments being exchanged in the domain swapping: the
N-terminal β1-α-β2 fragment and C-terminal β2-AS-β4-L2-β5
FIGURE 1 | Structure of (A) hCC monomer (stab1, PDB code: 3GAX) and (B) dimer (PDB code: 1G96). Valine residue in position 57 presented as magenta
sticks and leucine in position 68 presented as red sticks. Figure prepared using PyMol software.
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part (Jaskolski, 2001; Figure 1B). It is also the only structural
element that undergoes significant change during the domain
swapping process, turning from bent to extended conformation.
Such features make loop L1 a model example of the so-called
“hinge region.” Programs devoted to prediction of flexible pro-
tein fragments, potentially involved/responsible for the domain
swapping such as HingeProt, Fugue, or PoPMuSiC (Ding et al.,
2006; Emekli et al., 2008) point to cystatin C fragments cen-
tered around residues 43–59 as flexible and having preferences for
non-native conformation. Residues Q55IVAG59 forming loop L1
coincide with this prediction.
The second factor, significantly shifting the hCC monomer–
dimer ratio toward the dimer is unique to the natively occurring
cystatin C point mutant in which, due to single-nucleotide muta-
tion, native leucine is substituted by glutamine. Introduction of
a polar and sterically bigger side chain into the hydrophobic
core of the protein, at the interface between two labile domains
(Figures 1A,B), significantly destabilizes the molecule and, with
the aid of themolecular tensions within the hinge loop L1, leads to
pronounced dimerization and aggregation at physiological con-
ditions. Soluble hCC L68Q oligomers can be detected in body
fluids, but aggregation of this protein primarily affects the brain
(Olafsson et al., 1996). Accumulation of hCC L68Q deposits in
brain arteries leads to development of an amyloidogenic disease—
HCCAA, which is manifested by numerous hemorrhages, strokes,
and finally death, often before 40 years of age (Palsdottir et al.,
2006).
THE SEQUENCE OF THE HINGE LOOP AS A GATEKEEPER
OF THE WILD-TYPE CYSTATIN C CONFORMATIONAL
STABILITY
As it was mentioned above, the hCC loop L1 fulfills the require-
ments expected for the effective hinge region in the domain
swapping process. Comparison of its sequence with the data
for other cystatins available currently in the PDB database, and
further analysis in the context of the torsional ϕ and ψ angle
values revealed, that there is the amino acid residue display-
ing strained conformation, namely valine in position 57, located
near the apex of the loop (Rodziewicz-Motowidło et al., 2009;
Figure 1A). These tensions may be important for the biolog-
ical activity of cystatin C, but they may also account for its
increased dynamics, especially in the absence of the target pro-
tease. Therefore, we decided to perform theoretical studies in
order to assess the possibility of stabilization of the cystatin C
hinge loop by amino acid substitution. Molecular dynamics cal-
culations were performed for two mutations expected to stabilize
(V57D and V57N) and one that should additionally broaden the
loop L1 (V57P) and increase the tendency of hCC for opening
(Rodziewicz-Motowidło et al., 2009). Even though the mecha-
nism of the domain swapping, not only for cystatin C, but also
for other proteins, is still being discussed, there is an agree-
ment that the entire process must be preceded by at least partial
unfolding of the molecule (Liu et al., 2007). The most probable
places of such unfolding are flexible hinge regions, which, due to
their unique, molecular spring-like properties, may facilitate the
unfolding process. Therefore, all changes designed to stabilize or
at least limit the dynamics of the crucial fragment should lead
to stable monomeric form of the protein. The calculations per-
formed for hCC fragments encompassing β-hairpin formed by
β2-L1-β3 fragment (His43-Thr72) revealed, that even though for
all studied peptides the broadening of the structure was observed,
introduction of favored in turns Asp and Asn residues increased
conformational stability of the analyzed hCC fragment. On the
other hand, the V57P loop L1 variant was shown to exist in two
conformational states, separated by small, about 2 kcal/mol, free
energy barrier (Rodziewicz-Motowidło et al., 2009).
To verify the results of our calculations we have produced the
full length cystatin C variants with the appropriate mutations
introduced by means of site directed mutagenesis (Szyman´ska
et al., 2009). To our satisfaction, all mutants turned out to be
stable and soluble proteins, properly trafficked to the periplas-
mic space during bacterial over-expression and easy to isolate and
purify in high yields. Moreover, the cold osmotic shock isolation
and subsequent ion-exchange purification of the V57P mutant
yielded the protein as a dimer/monomer mixture, exactly as we
expected based on the molecular dynamics calculations results.
The asparagine and aspartic acid hCC counterparts at the same
conditions rendered monomeric.
Structural studies revealed that the introduced mutations do
not change significantly the secondary and tertiary structure of
the studied hCC variants. Circular dichroism measurements per-
formed in the far-UV range confirmed that all proteins display
predominantly α/β fold. However, lower values of themolar resid-
ual ellipticity observed for V57D and V57N variants, especially at
208 nm, suggest higher content or stability of the α-helical part for
these proteins. The content of the secondary structure elements
in proline mutant seems to be lower, comparing to other studied
proteins (including the wild-type hCC), but this difference may
result from different oligomeric (dimeric) state of this variant.
Similar fold of hCC hinge loop variants, including dimeric V57P,
was also confirmed by the near-UV CD (Szyman´ska et al., 2009).
Minor differences, concerning the position of a minimum of the
spectra, may be attributed to the form (monomeric vs. dimeric)
of the investigated molecules in solution, rather than significant
differences in their structure. Structural similarity of the pro-
line variant, however, did not correlate with its thermal stability
(Jankowska et al., 2008). Thermal unfolding of hCC V57P, moni-
tored by CDmeasurements at two wavelengths (218 and 222 nm)
revealed that, regardless the wavelength of observation, the mea-
sured Tm = 71◦C for this protein is lower by 10◦C than for other
hinge loop mutants (Jankowska et al., 2004, 2008). In contrast
to the wild-type hCC, proline, and two other variants unfold in
more cooperative manner and only one transition is observed
at both wavelengths. For native cystatin C two transitions can
be observed at 222 nm, one at 75◦C and one at 84◦C. Taking
into account that dimeric hCC predominates in solution at tem-
peratures in the range 65–80◦C (Ekiel and Abrahamson, 1996),
the first transition may depicts unfolding of already dimeric, but
not necessarily the domain-swapped protein. Formation of such
dimer must be preceded bymore pronounced changes in the hCC
structure, involving separation of the entire N-terminal domain,
containing also the helical part from the core of the molecule.
It is not very likely that such change would not be visible in
the CD spectrum. Therefore, it may be hypothesized that the
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first unfolding reflects changes leading to the formation of the
domain-swappedmolecule, which next unfolds at higher temper-
ature. Lowered thermal stability of the hCC α-helical part suggests
that the conformational changes leading to cystatin C unfolding
the most likely start at this region of the protein, and that this
structural element is important for the overall conformational
stability of the cystatin C.
The predicted increased or decreased stability of hCC vari-
ants in the monomeric form was further studied by monitoring
their susceptibility to undergo dimerization induced by denat-
urating agents. According to Ekiel, moderate concentration of
guanidine hydrochloride in the assay buffer accelerates signifi-
cantly the rate of the wild-type cystatin C dimerization in vitro.
Therefore, we have tested the behavior of all proteins during pro-
longed incubation in the presence of 0.5 and 1.0M GdnHCl in
PBS buffer (pH 7.4; Szyman´ska et al., 2009). Comparing to the
reference, the native cystatin C, very low degree of dimerization
was observed for the V57D and V57N variants at both studied
conditions (Table 1). The V57P mutant retained its dimeric state
during the incubation in the presence of lower concentration of
the destabilizing agent, whereas at 1.0M GdnHCl concentration
some increase in the monomer fraction was observed, suggesting
comparable stability of both forms at these conditions.
To further confront the results of our biochemical studies
concerning in-solution stability of hCC V57 mutants with the
proteins’ structure, we performed crystallization trials. The V57N
mutant occurred to be stable as a monomer and crystallized
in a monomeric form (Orlikowska et al., 2011b). The structure
of the mutant follows the cystatins’ general fold and consists
of a five-stranded antiparallel β-sheet wrapped around a long
central α-helix (PDB code: 3NX0). In the C-terminal part of
the molecule, two characteristic disulfide bridges are observed.
Comparison of hCC V57N and the dimeric, domain-swapped
structure of the wild-type cystatin C, revealed by Janowski et al.
(2001), confirmed that the general fold of the monomeric cys-
tatin molecule is duplicated in the structure of the dimeric hCC.
The only exception constitutes the L1 loop which undergoes
straightening during the domain swapping event and becomes
a part of an unusually long β-sheet, formed by two copies of
strands Tyr42-Thr74 (βL on Figure 1B). Interestingly, substitu-
tion of the strained valine residue with asparagine, regardless the
stabilization of the protein in the monomeric form, does not seem
to ease significantly the tensions within the loop L1. Comparison
of hCC V57N crystal structure with the published in 2010 first
crystal structure of the monomeric variant of hCC (Kolodziejczyk
et al., 2010), stabilized against domain swapping by “stitching”
the exchanging domains using the engineered disulfide bridge
(Cys47-Cys69), reveals high similarity of both loops (and the
whole molecules as well). The most significant distortions occur
at the dihedral angles of Val57 and Asn57 residues, placing them,
respectively, in additionally or generously allowed regions of the
Ramachandran plot and suggesting the strained conformation as
an inherent feature of the amino acid occupying this position
in hCC molecule. Similarity of all the remaining protein seg-
ments is an experimental proof that the structural perturbations
accompanying the dimerization process involve mainly or even
exclusively the L1 region. It provides also a strong support for the
hypothesis that the dimerization proceeds through relaxation and
opening of hCC structure, in which process the L1 loop plays an
important role.
Replacement of Val57 with aspartic acid was also intended to
preserve the L1 loop structure and prevent hCC dimerization.
We anticipated a reduced tendency for the dimer formation bas-
ing on the fact that, similarly to asparagine, aspartic acid residue
is frequently spotted in turn regions and it is known to stabi-
lize such conformations. Our expectations were also supported
by the results of the experiments performed on cC bearing V55D
mutation (equivalent to V57D in the human counterpart), which
showed the mutated protein as a monomer under all condi-
tions used to dimerize the wild-type cC (Staniforth et al., 2001).
Aspartic acid in the hinge loop of hCC, however, did not satisfy
the expectations in all respects. Although in chemical and thermal
denaturation processes V57N and V57D mutants demonstrated
significant and comparable stability of their monomeric forms
(Szyman´ska et al., 2009), in the crystal the V57D variant appeared
as a domain-swapped dimer (Orlikowska et al., 2010a, 2011a),
closely resembling the crystal form of the wild-type cystatin C.
The only difference between V57N andV57Dmutants is the char-
acter of the side chain of the amino acid replacing the residue
57. While this chain is merely polar in asparagine residue, in
aspartic acid at pH above 3.9 it takes a form of a carboxylate
anion. Insertion of the charged residue in the middle of the
Table 1 | Dimer content (%) formed by cystatin C and its hinge loop mutants incubated in the presence of different concentration of
guanidinium chloride (GdnHCl; Szyman´ska et al., 2009).
Conditions
PBS, pH 7.4 PBS, pH 7.4 PBS, pH 7.4
0.5M Gdn HCl 1.0M Gdn HCl
Start 9 days Start 9 days Start 9 days
hCC wt 3.30 0.20 6.42 31.43 77.22 77.46*
hCC V57D 2.14 2.78 1.02 8.13 9.34 15.72
hCC V57N 4.56 2.70 4.49 7.68 1.94 6.93
hCC V57P 80.40 64.83* 88.21 88.71 50.27 63.02
*Precipitation of the protein observed.
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extended β-sheet created by β2 and β3 strands in the dimeric
molecule may be expected to diminish the structure stability due
to repulsive interactions, and hence, should shift the equilibrium
toward the monomer. Preference of hCC V57D to exist as the
domain-swapped dimer suggests, that the spatial arrangement of
the side chain of D57 residue does not introduce repulsive inter-
actions. On the contrary, conformational change resulting from
the dimerizationmight enablemore favorable contacts of aspartic
acid side chain with the solvent molecules. These contacts might
be a source of the enthalpic gain stabilizing the dimer.
Proline is regarded as a residue which may play a pivotal role
in modulating domain swapping propensity in some proteins
(Bergdoll et al., 1997; Rousseau et al., 2001). We have decided to
introduce proline into the critical 57 position of hCC molecule
to test its power to induce the turn broadening and influence
hCC tendency to swap domains. In the case of this mutant results
of the denaturation studies went in line with the crystallization
experiments. In each tested condition V57P displayed enhanced
propensity to dimerization (Szyman´ska et al., 2009) and in the
crystal it was also a dimer (PDB code: 3S67; Orlikowska et al.,
2012). Rigidity of the proline cyclic side chain probably plays a
crucial role in the monomer destabilization causing escalation of
the backbone strain in the L1 loop region. The increased strain
makes this loop act as a loaded molecular spring that relieves
tension by adopting an alternative—extended conformation, trig-
gering partial unfolding of the protein molecule and subsequent
dimerization with domain swapping. Additionally, among the
studied cystatin C hinge loop variants, V57P exhibits highest
propensity for self-association, both in crystal (Orlikowska et al.,
submitted) and in solution.
Our approach toward stabilization of hCC in the monomeric
form, based on minimized structural intervention, limited to a
single-point mutation within the hinge region, turned out to be
partially successful. The obtained monomeric structure for V57N
and dimeric for V57P mutant confirmed validity of our strat-
egy. On the other hand, the dimeric structure of V57D variant
taught us a humility lesson. To our consolation, we have designed
and very recently resolved the crystal structure of yet another
monomeric cystatin C hinge loop variant (data not published).
Replacement of the critical valine residue with the simplest amino
acid—glycine, yielded exceptionally stable monomeric protein,
showing very low dimerization propensity in the in vitro tests
(Behrendt, 2010). The V57N and the V57Gmonomeric structures
are together an indication that it is possible to influence the pro-
tein dimerization propensity by manipulation in the sequence of
the hinge region, even if the scope of this manipulation is limited
only to a single-point mutation.
IMMUTABILITY OF THE HYDROPHOBIC INTERIOR
ESSENTIAL TO CYSTATIN C STABILITY
We have also studied the impact of the second “hot spot” in the
hCC sequence on its conformational stability. As it was men-
tioned above, the naturally occurring L68Q cystatin C variant
shows not only increased dimerization propensity (Nilsson et al.,
2004) but is also highly amyloidogenic (Abrahamson and Grubb,
1994). As it was proposed by Janowski, polar and sterically big-
ger glutamine residue, introduced into the hydrophobic core of
the molecule, can easily disrupt the network of hydrophobic
interactions stabilizing the α/β interface, triggering unfolding and
subsequent domain swapping (Janowski et al., 2001). Another
factor, accounting for increased dimerization propensity of the
hCC L68Q variant may be lowering of the unfolding energy
barrier due to reduction of the unfavorable solvent contacts
in the unfolded (or partially unfolded), more polar cystatin C
variant comparing to the wild-type protein. Results of our the-
oretical calculations, performed on model, monomeric forms
of both proteins confirmed fully above hypotheses and brought
some additional information about other consequences of the
introduced mutation (Rodziewicz-Motowidło et al., 2006). As
expected, in the amyloidogenic hCC variant the distance between
the α-helix and the β-sheet protein core is bigger by c.a. 0.4 Å
(9.13 Å for wt vs. 9.55 Å for L68Q variant). As a result, the variant
is less compactly folded and displays increased flexibility of the
exchangeable protein fragments. Expanding of the mutated pro-
tein molecule leads to increased solvent accessibility (by 6%) and
to weakening of the hydrogen bonds and salt bridges network.
Additionally, 23 kcal/mol difference of the non-bonded energy
value, calculated for the wild-type and L68Q cystatin C was pro-
posed by us as an additional driving force of the dimerization
process for the later protein (Rodziewicz-Motowidło et al., 2006).
In order to assess the impact of both, electrostatic and steric,
forces on cystatin C conformational stability in solution (sim-
ilarly to the loop L1) we designed additional hCC variants, in
which position 68 was occupied with hydrophobic but bigger
than leucine phenylalanine, hydrophobic and smaller valine and
isosteric to the native leucine but polar asparagine residue, respec-
tively. Among these proteins, only L68V mutant turned out to
be soluble and could be obtained in satisfactory yields from the
Escherichia coli periplasmic space, similarly to the hinge loop
variants. The other mutants, together with L68Q as a reference,
even though expressed in high yields, turned out to be contained
into inclusion bodies. All purification efforts yielded only low
milligram amounts (1–3mg) of proteins, with high propensity
for self-association and aggregation, which made more detailed
analyses impossible.
The only soluble and stable hydrophobic core variant of hCC,
L68V, could be purified in the monomeric form, but, comparing
to the wild-type cystatin C, it shows increased tendency for dimer-
ization (Orlikowska et al., 2010b), even under milder destabiliza-
tion conditions. This feature places hCC L68V variant between
the wild-type protein and the amyloidogenic L68Q mutant, sug-
gesting at the same time that the hydrophobic interactions within
the core of the hCC molecule are crucial for its stability. High
instability of the L68N hCC, comparable with destabilization
observed for the hCC L68Q and caused by the isosteric but polar
asparagine residue taking the place of the native leucine, supports
this hypothesis. In this case the steric effect can be considered as
negligible and the observed intramolecular destabilization must
arise from the disruption of hydrophobic interface between the α-
helix and the β-sheet core of the molecule, triggering its opening
and subsequent dimerization/oligomerization.
In the case of L68V, the interactions between the exchange-
able hCC domains are weakened due to the smaller van der Waals
radius of Val residue, but not to the point of changing the overall
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fold of the protein. Successful crystallization trials, performed at
two different conditions: pH 4.6; PDB code 3PS8, and pH 8.0;
PDB code 3QRD (Orlikowska et al., 2010b) yielded the domain-
swapped dimer, similar to the ones observed for the wild-type
protein and the two hinge loop hCC variants (Figure 2A). Closer
examinations of the surroundings of the substituted position 68
(Figure 2B) shows that the distance between the α-helix and the
β-sheet is the same in both dimers. Therefore, lowered stabil-
ity of the hCC L68V variant in the monomeric form cannot be
attributed to changes in the secondary or tertiary structure of
the studied protein, but, as proposed above, impaired interactions
between the α-helix and the C-terminal β-sheet.
The results obtained for the hydrophobic core hCC mutants
clearly indicate, that the integrity of the hydrophobic core of hCC
is crucial for its conformational stability. Introduction of polar,
not to mention charged, residue destabilizes the protein molecule
to the point of rendering it amyloidogenic. Higher, in relation to
L68Q and L68N, but lower, when compared with the hinge loop
mutants, stability of hCC L68V variant strengthens this hypoth-
esis, showing at the same time, that changes in this hCC region
are not well tolerated. The importance of the hydrophobic inter-
actions can be further supported by the observation, that the
deleterious effect of introduction of a polar glutamine residue
cannot be alleviated by stabilization of the hinge loop (Biernacka,
2010). Double hCC variants, containing both the L68Q andV57D
or V57N mutations, turned out to be either expressed in very low
yield or, due to either impaired cellular trafficking and/or folding,
easily degraded in vivo. Minute amounts obtained from the inclu-
sions bodies mimicked rather the properties of the hydrophobic
core, than the hinge loop variants displaying low thermal stability
and high propensity to first dimerization and next precipitation.
DISCUSSION
THE IMPACT OF THE MUTATIONS IN THE HINGE LOOP ON
OLIGOMERIZATION OF CYSTATIN C
Proteins from cystatin family are counted among the amyloido-
genic ones (Staniforth et al., 2001). This description stands for
both stefins (Zerovnik et al., 2010) and for cystatin C (especially
its L68Q variant) (Janowski et al., 2001). The mechanism of pro-
teins oligomerization and fibrillization is still being discussed,
especially the transformation of the soluble oligomeric species
into mature fibrils (Uversky, 2010) and the role and structure
of the oligomers and folding intermediates in the aggregation
process (Jahn and Radford, 2008; Skerget et al., 2009; Stefani,
2012). Tomake the picture more complex, there are also proposed
different models of proteins’ ordered aggregation into fibril-
lar structures (Zerovnik et al., 2011) among which the domain
swapping mechanism is being considered as the one involved in
fibrillization of, e.g., prion proteins (Hafner-Bratkovicˇ and Jerala,
2011) and cystatins (Wahlbom et al., 2007; Zerovnik et al., 2011).
The direct proof for the connection between these two processes
in the case of cystatin C was provided by Wahlbom and cowork-
ers, who has shown, that inhibition of the domain swapping by
covalent linking of the exchanging protein’s parts abolishes also
its fibrillization. Having in hands other cystatin C mutants with
modulated dimerization tendency, we decided to check also their
tendency for further oligomerization (Szyman´ska et al., 2008).
According to Wahlbom, cystatin C incubated in an acidic buffer
(pH 4.0) at elevated temperature and with continuous agita-
tion forms doughnut-shaped oligomeric forms (Wahlbom et al.,
2007) via propagated domain swapping (“run-away”) mecha-
nism. The hCC hinge loop mutants were also subjected to similar
studies. Protein samples were incubated at conditions promot-
ing oligomerization for 2 h and the results were checked using
gel filtration on Superdex 75 column equilibrated in the assay
buffer. The analysis of the obtained data revealed that all stud-
ied proteins are capable of forming oligomers higher than dimers
(Figure 3). For all three analyzed mutants the main oligomeric
form had retention time about 11min which, based on the col-
umn calibration, is expected for the hexameric assembly of the
protein (Figure 3, peak H, MW ca. 80 kD). The highest content of
monomers in the incubated samples was observed for the V57N
protein, which was shown to be the least dimerization-prone. In
the case of the initially dimeric proline mutant the majority of
the protein was in the form of a putative hexamer. Interestingly,
significant amount of the dimeric form was observed only for
FIGURE 2 | Comparison of (A) the crystal structure of hCC wt
(red, PDB code: 1G96) and its variants: L68V (green—pH 4.0, PDB
code: 3PS8; cyan—pH 8.0, PDB code: 3QRD) and V57P (blue, PDB:
3S67); (B) molecular contacts of Val68 (van der Waals radius as
green dots) and Leu68 (gray dots) residues. Figure prepared using
PyMol software.
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FIGURE 3 | Gel filtration of oligomerized hCC wt (black) and its hinge
loop mutants: V57D (green), V57N (red), and V57P (blue). Protein
samples were incubated in 50mM AcONa (pH 4.0), 100mM NaCl at 48◦C
for 2 h with constant mixing and subjected onto Superdex 75 column
equilibrated in the same buffer. In the inset chromatograms of the protein
samples before incubation are presented. Peak descriptions: M,
monomeric hCC; D, dimeric (domain swapped) hCC; H, putative hexameric
hCC assembly; V, higher hCC oligomers eluted in the void volume of the
column. The SEC elution profiles are given for a better illustration of the
data described in Szyman´ska et al. (2008).
the native hCC, for which the H peak was much lower than
for the other studied proteins. Additionally, for the wt pro-
tein, formation of higher oligomers was observed (Figure 3, peak
V). The exact molecular weight of this specimen could not be
determined due to its elution in the void volume of the SEC col-
umn used in this experiment. Application of the column with
higher exclusion limit (Superdex 200) also did not bring reliable
information.
In order to get a deeper insight into oligomerization of
hCC variants all samples subjected to gel filtration were also
inspected under the electron microscope (Szyman´ska et al., 2008).
For the V57D and V57N variants the presence of any defined
structural form was not observed (Figures 4B,C). The proline
mutant formed at the same conditions few circular and irregu-
lar aggregates (Figure 4D), whereas for the native protein a new
type of a structural object was observed (Figure 4A). In addition
to doughnut-shaped oligomers reported previously by Wahlbom
and co-workers, electron micrographs recorded after 2 h of incu-
bation demonstrated rod-like structures with the outer diameter
of 17 ± 2 nm and length of 100 ± 20 nm. The population of these
oligomers seems to be quite homogeneous. The size of both
FIGURE 4 | Electron micrographs of cystatin C oligomers (A) HCC wt,
(B) HCC V57D, (C) HCC V57N, and (D) HCC V57P. Oligomers were
produced by incubation of protein samples at 3mg/ml concentration in
50mM AcONa (pH 4.0), 100mM NaCl, with continuous agitation at 48◦C for
2 h. Bar representing 50 nm is shown as an indicator of the size. Protein
samples were negatively stained with 2% (w/v) aqueous uranyl acetate for
30 s and examined with a Philips CM10 electron microscope (Philips,
Eindhoven, The Netherlands), operating at an excitation voltage of 100 kV.
The EM data were presented on a conference and were described but not
reproduced in Szyman´ska et al. (2008). Here, the image (unpublished
before) is given in order to enable better discussion.
rods and “doughnuts” is slightly bigger than the ones observed
before. We hypothesize that the rod-like specimen may corre-
spond to the pre-fibrillar intermediate of hCC formed by the
protein undergoing the domain swapping in the propagatedman-
ner (“run-away” domain exchange model), “caught” at the point
before it transforms to insoluble fibrils. The other possibility,
which we cannot rule out, is that the observed rods are consti-
tuted of the “doughnuts” stacked on each other. Dimensions of
the observed specimen, that is the outer diameter bigger than the
diameter of the typical amyloid fibril and much shorter length,
suggest that, in such a case, additional conformational change
would be necessary for the mature fibril formation. Additionally,
these structures did not display any increase in ThT fluorescence
observed for amyloid fibrils (data not shown).
The lack of analogous structures for the rest of the studied hCC
variants may suggest the important role of the domain swapping
capability of a particular protein in their formation. Additionally,
the lack of the rod-like oligomers for the hCC V57P, which is
predominantly dimeric, may strengthen the hypothesis of the
propagated manner of the domain exchange process. The dimer
formed by this variant may be too stable to undergo opening and
further oligomerization in the “run-away” mode.
CONCLUSIONS AND FURTHER DIRECTIONS
The results obtained for two groups of cystatin C variants: the
hinge loop and the hydrophobic core mutants, show that the
main stabilization force of the hCC molecule comes from the
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hydrophobic interactions responsible for holding together the α-
helix and the C-terminal part of the molecule. Changes within
these regions increase the propensity of the hCC toward dimer-
ization and oligomerization, which cannot be easily compensated
by stabilization of the hinge loop sequence. However, in the
case of the wild-type protein, its stability in biologically active,
monomeric form may be easily manipulated by changes in the
hinge region sequence. The access to stable monomeric and
dimeric forms of cystatin C, with marginally changed primary
structure and available in high amounts is beneficial from the
point of view of more detailed studies of the mechanism of
the domain swapping in cystatin C as well as the implication
between domain swapping, dimerization and oligomerization.
Our approach based on the rational mutagenesis yielded a pool
of data that encourages us to perform further studies of the hCC
dimerization mechanism, especially of the early stages of this
process and the role of the helical part. The next steps are there-
fore the folding studies of all obtained cystatin C variants and
dissecting the mechanism of their functional or aberrant out-
come leading to protein fibrillization. The knowledge concerning
thermodynamics and kinetics of the hCC folding, especially the
number and nature of intermediates, should provide the infor-
mation crucial for better understanding of hCC aggregation
process. Additionally, in the future work we intend to com-
pare the folding mechanism and fibrillization propensities of
the cystatin C mutants with the data obtained for other amy-
loidogenic proteins, not only stefins (Jenko et al., 2004; Kenig
et al., 2006; Jelinska et al., 2011). The outcome of such stud-
ies could be used to verify the hypothesis about the connection
between protein stability, the folding mechanism and fibrilization
propensities.
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